Access to childhood cancer medicines in South Africa: a health systems analysis of barriers and enablers

References

• Boateng, R., Petricca, K., Tang, B., Parikh, S., SinQuee-Brown, C., Alexis, C., Browne-Farmer, C., Reece-Mills, M., Salmon, S. M., Bodkyn, C., Gupta, S., Maguire, B., & Denburg, A. E. (2021). Determinants of access to childhood cancer medicines: A comparative, mixed-methods analysis of four Caribbean countries. The Lancet Global Health, 9(9), e1314–e1324. https://doi.org/10.1016/S2214-109X(21)00287-4
   PubMed Web of Science ®Google Scholar
• Boateng, R., Renner, L., Petricca, K., Gupta, S., & Denburg, A. (2020). Health system determinants of access to essential medicines for children with cancer in Ghana. BMJ Global Health, 5(9), e002906.
   PubMed Web of Science ®Google Scholar
• Charmaz, K. (2014). Constructing grounded theory.
   Google Scholar
• Council for Medical Schemes. (2020). The medical schemes industry in 2020. Retrieved May 15, 2023 from https://www.medicalschemes.co.za/the-medical-schemes-industry-in-2020/.
   Google Scholar
• Denburg, A. E., Knaul, F. M., Atun, R., Frazier, L. A., & Barr, R. D. (2014). Beyond the bench and the bedside: Economic and health systems dimensions of global childhood cancer outcomes. Pediatric Blood & Cancer, 61(3), 572–576.
   PubMed Web of Science ®Google Scholar
• Gordon, T., Booysen, F., & Mbonigaba, J. (2020). Socio-economic inequalities in the multiple dimensions of access to healthcare: The case of South Africa. BMC Public Health, 20(1), 289. https://doi.org/10.1186/s12889-020-8368-7
   PubMed Web of Science ®Google Scholar
• Institute for Health Metrics and Evaluation. (n.d.). South Africa. Retrieved May 17, 2023 from https://www.healthdata.org/south-africa.
   Google Scholar
• Joosse, I. R., van den Ham, H. A., Mantel-Teeuwisse, A. K., & Suleman, F. (2023). Alignment in the registration, selection, procurement and reimbursement of essential medicines for childhood cancers in South Africa. BMJ Global Health, 8(9), e012309. https://doi.org/10.1136/bmjgh-2023-012309
   PubMed Web of Science ®Google Scholar
• Joosse, I. R., van den Ham, H. A., Mantel-Teeuwisse, A. K., & Suleman, F. (2024). A proposed analytical framework for qualitative evaluation of access to medicines from a health systems perspective. BMC Research Notes, 17(1), 159. https://doi.org/10.1186/s13104-024-06764-1
   PubMed Web of Science ®Google Scholar
• Magadzire, B. P., Ward, K., Leng, H. M. J., & Sanders, D. (2017). Inefficient procurement processes undermine access to medicines in the Western Cape province of South Africa. South African Medical Journal = Suid-Afrikaanse Tydskrif vir Geneeskunde, 107(7), 581–584.
   PubMed Web of Science ®Google Scholar
• Makoni, M. (2021). Palliative care for children with cancer in South Africa. The Lancet Child & Adolescent Health, 5(4), 241–242. https://doi.org/10.1016/S2352-4642(21)00065-1
   Google Scholar
• Maser, B., Force, L., Friedrich, P., Atun, R., & Denburg, A. E. (2020). Pediatric oncology system integration tool (POSIT): A health systems performance assessment framework for childhood cancer care in low- and middle-income countries. Journal of Cancer Policy, 23, 100208. https://doi.org/10.1016/j.jcpo.2019.100208
   Web of Science ®Google Scholar
• Mattila, P. O., Babar, Z. U., & Suleman, F. (2021). Assessing the prices and affordability of oncology medicines for three common cancers within the private sector of South Africa. BMC Health Services Research, 21(1), 661. https://doi.org/10.1186/s12913-021-06627-6
   PubMed Web of Science ®Google Scholar
• Meyer, S., Nqabeni, G., & Tsotetsi, N. (2021). Access to cancer medicines in South Africa. Cancer Alliance Report CA03/2021.
   Google Scholar
• Meyer, S., Tsotetsi, N., Nqabeni, G., & Conradie, M. (2022). Analysis of oncology benefits offered by 10 medical schemes in South Africa. Retrieved June 2024 from https://canceralliance.org.za/wp-content/uploads/2022/07/Oncology-benefits-from-medical-schemes-in-South-Africa_02.pdf.
   Google Scholar
• Michel, J., Tediosi, F., Egger, M., Barnighausen, T., McIntyre, D., Tanner, M., & Evans, D. (2020). Universal health coverage financing in South Africa: Wishes vs reality. Journal of Global Health Reports, 4, e2020061.
   Google Scholar
• Modisakeng, C., Matlala, M., Godman, B., & Meyer, J. C. (2020). Medicine shortages and challenges with the procurement process among public sector hospitals in South Africa; findings and implications. BMC Health Services Research, 20(1), 234. https://doi.org/10.1186/s12913-020-05080-1
   PubMed Web of Science ®Google Scholar
• Naidoo, S. (2012). The South African national health insurance: A revolution in health-care delivery! Journal of Public Health, 34(1), 149–150. https://doi.org/10.1093/pubmed/fds008
   PubMed Web of Science ®Google Scholar
• Naidoo, V., Suleman, F., & Bangalee, V. (2023). Policy developer's perceptions on the implementation of national health insurance in South Africa: A qualitative study. Journal of Pharmaceutical Policy and Practice, 16(1), 61.
   PubMed Web of Science ®Google Scholar
• Petricca, K., Kambugu, J., Githang'a, J., Macharia, W. M., Njuguna, F., McLigeyo, A., Nyangasi, M., Orem, J., Kanyamuhunga, A., Laiti, R., Katabalo, D., Schroeder, K., Rogo, K., Maguire, B., Wambui, L., Nkurunziza, J. N., Wong, B., Neposlan, J., Kilawe, L., … Denburg, A. E. (2023). Access to essential cancer medicines for children: A comparative mixed-methods analysis of availability, price, and health-system determinants in east Africa. The Lancet Oncology, 24(5), 563–576. https://doi.org/10.1016/S1470-2045(23)00072-4
   PubMed Web of Science ®Google Scholar
• Stefan, D. C., & Siemonsma, F. (2011). Delay and causes of delay in the diagnosis of childhood cancer in Africa. Pediatric Blood & Cancer, 56(1), 80–85. https://doi.org/10.1002/pbc.22714
   PubMed Web of Science ®Google Scholar
• Stones, D. K., De Bruin, G. P., Esterhuizen, T. M., & Stefan, D. C. (2014). Childhood cancer survival rates in two South African units. South African Medical Journal = Suid-Afrikaanse Tydskrif vir Geneeskunde, 104(7), 501–504.
   PubMed Web of Science ®Google Scholar
• Suleman, F., & Gray, A. (2017). Pharmaceutical policy in South Africa. In Z. Babar (Ed.), Pharmaceutical policy in countries with developing healthcare systems (pp. 285–302). Springer International Publishing.
   Google Scholar
• van Heerden, J., Esterhuizen, T., & Kruger, M. (2021). Inequity in paediatric oncology in South Africa–The neuroblastoma case study. South African Journal of Oncology, 5(0), 163.
   Google Scholar
• van Heerden, J., Lisa Christine, I., Downing, J., Davidson, A., Hessissen, L., Schoeman, J., Ladas, E. J., Abdelhafeez, H., Georgia Odongo Arao, S., Fentie, A. M., Kamal, S., Parkes, J., Naiker, T., Ludick, A., Balagadde-Kambugu, J., & Geel, J. (2023). Current status of African pediatric oncology education efforts aligned with the global initiative for childhood cancer. Pediatric Hematology and Oncology, 40(3), 224–241. https://doi.org/10.1080/08880018.2022.2117882
   PubMed Web of Science ®Google Scholar
• Ward, Z. J., Yeh, J. M., Bhakta, N., Frazier, A. L., Girardi, F., & Atun, R. (2019). Global childhood cancer survival estimates and priority-setting: A simulation-based analysis. The Lancet Oncology, 20(7), 972–983. https://doi.org/10.1016/S1470-2045(19)30273-6
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2021). Cureall framework: WHO global initiative for childhood cancer. Increasing access, advancing quality, saving lives. World Health Organization.
   Google Scholar